Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Absci Corporation

< Previous 1 2 Next >
Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Announces Pricing of Public Offering of Common Stock
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Announces Proposed Public Offering of Common Stock
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Appoints Biopharma Leader Mary Szela to Board of Directors
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the KeyBanc Capital Markets Healthcare Forum
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the TD Cowen 45th Annual Health Care Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery
From Absci Corporation
Via GlobeNewswire
Tickers ABSI AMD
Absci to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Host R&D Day on December 12, 2024
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI
From Absci Corporation
Via GlobeNewswire
Tickers ABSI TWST
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.